Literature DB >> 9166042

Ribavirin and bronchiolitis: variation in use in the UK.

T D Allport, E G Davies, C Wells, M Sharland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9166042      PMCID： PMC1717148          DOI： 10.1136/adc.76.4.385

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  7 in total

1.  Preventing respiratory syncitial virus bronchiolitis.

Authors:  M Sharland; A Bedford-Russell
Journal:  BMJ       Date:  2001-01-13

2.  Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis.

Authors:  Mark J C Nuijten; Wolfgang Wittenberg; Maximilian Lebmeier
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Hospitalisation for RSV infection in ex-preterm infants-implications for use of RSV immune globulin.

Authors:  M Thomas; A Bedford-Russell; M Sharland
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

4.  Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection.

Authors:  L H Thomas; M I Wickremasinghe; M Sharland; J S Friedland
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families.

Authors:  J Hull; A Thomson; D Kwiatkowski
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

6.  Haplotype mapping of the bronchiolitis susceptibility locus near IL8.

Authors:  Jeremy Hull; Kate Rowlands; Elizabeth Lockhart; Mike Sharland; Catrin Moore; Neil Hanchard; Dominic P Kwiatkowski
Journal:  Hum Genet       Date:  2003-11-06       Impact factor: 4.132

7.  Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains.

Authors:  R Gasparini; P Durando; F Ansaldi; L Sticchi; F Banfi; D Amicizia; D Panatto; S Esposito; N Principi; G Icardi; P Crovari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.